# C_2012210EN.01001101.xml

| 17.7.2012 | EN | Official Journal of the European Union | C 210/11 |
| --- | --- | --- | --- |

17.7.2012

EN

Official Journal of the European Union

C 210/11

---

Prior notification of a concentration

(Case COMP/M.6560 — EQT VI/BSN Medical)

(Text with EEA relevance)

2012/C 210/09

| 1. | On 9 July 2012, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking EQT VI (‘EQT VI’, Guernsey, the UK), part of the EQT group of private equity funds (‘EQT’, Guernsey, the UK), acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of BSN medical Acquisition Holding GmbH (‘BSN medical Acquisition Holding’, Germany) and BSN medical Netherlands Holding BV BSN medical Netherlands (‘BSN medical Netherlands’, the Netherlands) and their respective subsidiaries (collectively ‘BSN Medical’) by way of purchase of shares. |
| --- | --- |

1.

On 9 July 2012, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking EQT VI (‘EQT VI’, Guernsey, the UK), part of the EQT group of private equity funds (‘EQT’, Guernsey, the UK), acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of BSN medical Acquisition Holding GmbH (‘BSN medical Acquisition Holding’, Germany) and BSN medical Netherlands Holding BV BSN medical Netherlands (‘BSN medical Netherlands’, the Netherlands) and their respective subsidiaries (collectively ‘BSN Medical’) by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:






  — | EQT VI: investment fund making investments primarily in Northern Europe, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

EQT VI: investment fund making investments primarily in Northern Europe,

| — | EQT: a group of private equity funds, which are managed independently and on their merits and are not, even within respective fund, financially or operationally consolidated, |
| --- | --- |

—

EQT: a group of private equity funds, which are managed independently and on their merits and are not, even within respective fund, financially or operationally consolidated,

| — | BSN Medical: a medical device company that develops, manufactures and markets wound care, compression therapy and orthopedics products. |
| --- | --- |

—

BSN Medical: a medical device company that develops, manufactures and markets wound care, compression therapy and orthopedics products.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope the EC Merger Regulation. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope the EC Merger Regulation. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6560 — EQT VI/BSN Medical, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6560 — EQT VI/BSN Medical, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

1

---